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that when sufficient amounts of noradrenaline are present, aged VAT explants have normal catecholamine signalling to induce lipolysis.
Macrophages drive inflammation and influence lipid homeostasis 9,10 , we therefore investigated whether adipose tissue macrophages (ATMs) control the fasting-induced lipolysis defect in ageing. Surprisingly, unlike in obesity, in which the number of macrophage increase in VAT [11] [12] [13] , aged mice had a reduced frequency of F4/80 + CD11b + ATMs (Fig. 1c , Extended Data Fig. 2a ). Compared to fed mice, the young fasted mice show a greater reduction in CD11c + CD206 − ATMs with corresponding increases in CD11c + CD206 + ATMs, a response that is impaired in aged mice (Extended Data Fig. 2b, c ), suggesting altered functionality of aged ATMs.
To determine the functional role of aged macrophages in lipolysis, adipocytes generated from progenitor cells (Lin − CD29 + CD34 + Sca1 + ) of young mice were stimulated with noradrenaline and co-cultured with F4/80 + CD11b + macrophages sorted from the VAT of aged mice. We found that only the aged ATMs inhibited FFA release from noradrenaline-stimulated young adipocytes (Fig. 1d, top) . Conversely, the addition of ATMs sorted from young mice partially restored lipolysis in VAT explants obtained from fasted aged mice (Fig. 1d , bottom and Extended Data Fig. 2d ), suggesting that ageing induces specific defects in ATMs to inhibit noradrenaline-induced lipolysis in VAT.
To determine how aged ATMs impair adipocyte lipolysis, we performed whole transcriptome gene expression analysis (Fig. 1e , schematic). Aged ATMs showed an enrichment of metabolic Gene Ontology (GO) terms ( Fig. 1e ), including all classes of carbon metabolism (GO term 'organic substance metabolic process') ( Fig. 1e , bar chart). Notably, aged ATMs expressed a higher percentage of genes that regulate the metabolism of catecholamines ( Fig. 1e, f) . Notably, monoamine oxidase A (Maoa) and downstream enzymes, aldehyde dehydrogenases (Aldh genes) and Aldo-keto reductases (Akr genes) are known to convert primary amines such as catecholamines into aldehydes, ammonia and hydrogen peroxide 14 (Fig. 1f, inset) . In agreement, ageing upregulates MAOA protein 15 (Extended Data Fig. 2e ). Collectively, these data suggest a link between reduced adipocyte lipolysis and increased catecholamine catabolism machinery in ATMs during ageing.
We next investigated the nature and specificity of metabolic defects in aged ATMs. Principal component analysis (PCA) revealed tissue-and ageing-induced clustering of VAT and splenic macrophages (Extended Data Fig. 3a-d ) with distinct transcriptional signatures (Extended Data Fig. 3c, d) . Moreover, ATMs failed to show clustering with macrophages from liver, lung, brain, peritoneum or intestines (Extended Data Fig. 3e ), consistent with specialized function of ATMs 16 . Furthermore, co-expression analysis identified 1,887 highly connected genes with age, and these were visualized as a network (Extended Data Fig. 4a, b) . Again, tissue differences comprise the largest functional separation (left versus right panels), and gene filtering identified specific enrichment of lipid and metabolic genes in ATMs and not in splenic macrophages (Extended Data Fig. 4c ). Linear support vector regression to map the multi-dimensional model of in vitro macrophages activated by 29 different stimuli failed to show enrichment within aged VAT and splenic macrophage transcriptome analysis ( Fig. 2a ). These results demonstrated that aged splenic macrophages and ATMs lack the 'M1 or M2' polarization state and share similarities to a multitude of macrophage activation states.
Consistent with previous reports 17, 18 , RNA sequencing (RNA-seq) analysis of ATMs also revealed that ageing is associated with activation of the Nod-like receptor (NLR) pathway and Casp1 (Fig. 2b) .
To determine whether NLRP3 inflammasome activation directly influences lipolysis, bone marrow-derived macrophages (BMDMs) were stimulated with LPS and ATP and subsequently washed and co-cultured with young VAT explants stimulated by noradrenaline. Interestingly, inflammasome-activated macrophages significantly inhibited the release of glycerol from VAT (Fig. 2c) in an NLRP3dependent manner (Fig. 2d) . Notably, 2-year-old Nlrp3 −/− mice were protected from the impaired fasting-induced lipolysis seen in ageing ( Fig. 2e ). Collectively, these data demonstrate that the NLRP3 inflammasome controls reduced catecholamine-driven lipolysis in ageing.
We next studied how NLRP3 inflammasome activation in macrophages controls fasting-induced lipolysis in ageing. Interestingly, the ablation of Nlrp3 protected against the age-related loss of F4/80 + CD11b + ATMs in VAT ( Fig. 3a ) and the alteration of CD206 and CD11c expression on ATMs (Extended Data Fig. 5a , b) without affecting VAT dendritic cells or splenic macrophages (Extended Data Fig. 5c-e ). RNA-seq revealed that a select set of genes regulated by ageing in ATMs (Extended Data Fig. 6a -c) and splenic macrophages was dependent on Nlrp3 (Extended Data Fig. 6d-f ), including an enrichment of genes implicated in cell-senescence in aged ATMs that were reciprocally regulated by Nlrp3 (Extended Data Fig. 7a, b) 19 . Given that ATMs are maintained by proliferation 20 , a reduction in macrophage frequency in aged VAT may reflect an exhausted senescent-like ATM profile driven by sustained NLRP3 inflammasome activation. The growth differentiation factor-3 (Gdf3) gene, which controls adiposity 21, 22 , was the most highly upregulated gene with age, and was downregulated after ablation of Nlrp3 to levels on a par in young mice (Fig. 3b ). Nlrp3 deficiency in ageing also restored lipid metabolism genes (Extended Data Fig. 7c ) and catecholamine-catabolism genes such as Maoa, Comt and Aldh and Akr family members ( Fig. 3c ).
Again, compared to aged ATMs, the splenic macrophages exhibited distinct transcriptional signatures and catechol amine catabolism gene regulation by age and Nlrp3 (Extended Data Figs 6c, e, f and 7d). These results suggest that activation of NLRP3 inflammasome in aged ATMs upregulates biogenic-amine degradation machinery. On the basis of our finding that Gdf3 is the top regulated gene by age and Nlrp3 (Fig. 3b ), we next investigated the mechanism of NLRP3 inflammasome-induced impaired lipolysis. GDF3 is a TGFβ family member that is secreted by macrophages and ligates several receptors, including nodal or activin-like kinase-7 (ALK7), on adipocytes to inhibit catecholamine-induced lipolysis 23, 24 . In agreement, VAT from Gdf3 −/− mice show increased glycerol release ( Fig. 4a ), suggesting that high levels of GDF3 inhibit lipolysis. Interestingly, an age-induced increase in Pcsk6, which cleaves and activates nodal and ALK7 to promote GDF3 signalling 22 , is also regulated by Nlrp3 (Extended Data Fig. 8a ). Furthermore, ablation of Gdf3 inhibited the NLRP3 inflammasome activation in BMDMs (Fig. 4b , Extended Data Fig. 8b , c) by downregulating the transcriptional priming 'signal-1' , as evidenced by reduced Casp1 and Il1b gene expression (Extended Data Fig. 8c, d) , and decreased NFκ B activation (Extended Data Fig. 8e ). In line with these data, Gdf3-deficient BMDMs failed to impair the inflammasomeinduced VAT lipolysis (from wild-type explants) ( Fig. 4c) TPP+IFNβ+IFNγ  TPP+IFNβ  TPP  TNF+P3C  TNF+PGE 2  sLPS+IC  sLPS+IFNγ  sLPS  IFNγ+TNF  TNF  IFNγ  PA  SA  LiA  OA  LA  PGE 2  P3C  P3C+PGE 2  upLPS  upLPS+IC  IL4+upLPS  IL13  IL4  GC  IL10 Exact n values are shown in parentheses (c-e), and further described in the Letter reSeArCH ablation of Gdf3 inhibited the inflammasome-induced expression of Maoa ( Fig. 4d and Extended Data Fig. 8f ), implicating NLRP3 inflammasome activation-induced Gdf3 in upregulation of macrophage catecholamine-degradation machinery and resultant downstream reduction in VAT lipolysis.
Given the crucial role of MAOA in noradrenaline degradation 25 , we next investigated whether ATMs have direct access to catecholamines produced by the sympathetic nerve. VAT of transgenic mice in which the myeloid-lineage cells are indelibly marked by membrane green fluorescent protein (GFP) (Extended Data Fig. 9a , b) revealed a population of nerve-associated macrophages (NAMs) that are in close association with the tyrosine hydroxylase-expressing sympathetic nerve fibres ( Fig. 4e ). Indeed, previous studies suggest that macrophages can express MAOA and also uptake noradrenaline 26, 27 . Thus, the interaction of macrophages with the sympathetic nerve, and the gene expression of catecholamine-catabolic machinery in aged mice, support a model in which nerve-associated macrophages have direct access to catecholamines produced by the sympathetic nerve to regulate adipocyte access to noradrenaline.
To understand the relevance of increased MAOA in macrophages, we treated BMDMs with clorgyline, an irreversible inhibitor of MAOA activity that is clinically used to increase catecholamine levels and to treat depression 28 . Inhibition of MAOA in inflammasome-activated macrophages by clorgyline restored noradrenaline-induced lipolysis ( Fig. 4f ). To determine the therapeutic potential of MAOA inhibitors, aged mice were treated with clorgyline (2 mg kg −1 body weight) and fasted for 24 h. In vivo, the clorgyline treatment of aged mice restored fasting-induced lipolysis ( Fig. 4g ) and rescued the age-related reduction in the phosphorylation of hormone sensitive lipase (HSL), expression of adipose triglyceride lipase (ATGL) ( Fig. 4h ), increased expression of UCP-1 protein ( Fig. 4i ) and restored noradrenaline levels in VAT of old mice (Fig. 4j ). These data are consistent with the hypothesis that during ageing, increased noradrenaline degradation drives reduced lipolysis and not catecholamine-signalling resistance (Extended Data Fig. 9c ).
Collectively, our findings offer insights into the role of age-related chronic inflammation driven by NLRP3 inflammasome as a driver of macrophage-sympathetic nervous system interactions that control catecholamine catabolism to regulate lipolysis. How nerve-associated macrophages sense 'stranger or danger' signals and then convey information to the sympathetic nervous system to regulate behaviour, metabolism, inflammation and defence against neurotropic viruses warrants further study. Future studies to regulate macrophage activity and catecholamine bioavailability in tissues may reveal new approaches to improve health through the mobilization of ectopic lipid.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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Animal care. All mice were housed in specific pathogen-free facilities in ventilated cage racks that deliver HEPA-filtered air to each cage with free access to sterile water through a Hydropac system at Yale School of Medicine. Sentinel mice in our animal rooms were negative for currently tested standard mouse pathogens (Ectromelia, EDIM, LCMV, Mycoplasma pulmonis, MHV, MNV, MPV, MVM, PVM, REO3, TMEV and Sendai virus) at various times while the studies were performed (Research Animal Diagnostic Laboratory). C57BL6/J (wild-type) mice were bred from our colony, purchased from Jackson Laboratories or received from the National Institute of Ageing Rodent colony. Nlrp3 −/− have been previously described and were bred in our facility, along with their wild-type controls 29 . LysM-cre mT/mG mice were bred in our facility. Gdf3 −/− mice have been described previously 21 and were bred in our colony. All knockout mice were compared to littermate controls raised in the same facility. All experiments and animal use were conducted in compliance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at Yale University. Experimental design and statistical analysis. No statistical methods were used to predetermine sample size. Blinding of investigators was not possible during experiments. Control and experimental groups were randomly assigned by cage. All experiments contained littermates and non-littermates, which were both randomly assigned to control and experimental group. Young control mice were raised or obtained from the same facility as the aged mice. An 'n' for each experiment was used based on preliminary and published experiments, which identified n values needed for statistical analysis. Statistical significance was calculated by a two-tailed Student's t-test or ANOVA using a post-hoc test to correct for multiple hypotheses. * P < 0.05; * * P < 0.005; * * * P < 0.001; * * * * P < 0.0001. GraphPad Prism was used to define statistical outliers, which were then excluded from data analysis. A confidence interval of 95% was used for all statistical tests. All data were assumed to be normally distributed, unless the standard deviation was identified as significantly different between groups. In this case a non-parametric test was used. All statistical tests were performed using GraphPad Prism v7 for Windows (GraphPad Software). Data are expressed as mean ± s.e.m. Biological replicates and the number of independent experiment repetition are described in the figure legends. All biological replicates and pooled values for experiments requiring adipose tissue digestion and stromavascular fraction analysis are described in the next section. Biological variation was maintained during pooling, therefore all numeric data and statistical analyses are derived from biological replicates. Numbers of mice and biological replicates used in mouse experiments requiring adipose pooling. Biological variation was maintained when pooling tissue; only tissue needed to reach desired tissue amount (for example, 0.5 g, typically from 2-3 mice to generate one biological replicate) were pooled for analyses. The descriptions below list the figure and the individual mouse number and biological replicates that were used to generate the data. Figure 1c and Extended Data Fig. 2b , c contain 13 4-month fed wild-type mice; 10 21-month fed wild-type mice; 16 4-month fasted wild-type and 11 21-month fasted wild-type individual mice. These samples were pooled to make n = 3, 4-month fed wild-type, n = 9, 21-month fed wild-type, n = 3, 4-month fasted wild-type, and n = 8, 21-month fasted wild-type independent samples. These samples were pooled to make n = 3, n = 4, n = 5, n = 4, n = 3, n = 3, n = 6 and n = 4 independent samples. Adipose digestion and stromavascular staining. Visceral adipose was collected at euthanization and weighed. Tissue was enzymatically digested in 0.1% collagenase I (Worthington Biochemicals) in HBSS (Life Technologies) for 45 min at 37 °C. Tissue from control and experimental groups was digested and stained on the same day to eliminate minor procedure differences. The stromavascular fraction was pelleted by centrifugation at 500g for 10 min, then washed and filtered. Red blood cells are lysed using ACK lysis buffer. Cells were resuspended in 1 ml for counting before staining. For staining, the stromavascular fraction was incubated with FcBlock, surface antibodies for 30 min on ice, in the dark, then washed and stained with Fixable Viability Dye (eBioscience) and intracellular antibodies using cytofix (BD Biosciences). Analysis was performed on a BD LSRII and using FlowJo vX.
For sorting ATMs: CD3 − B220 − F4/80 + CD11b + cells were sorted on a BD FACS Aria into RPMI plus 20% FBS. Cells were pelleted and resuspended in trizol for RNA isolation or media for co-culture with adipocytes or whole VAT. Lipolysis assay. For ex vivo lipolysis assay, adipose tissue was collected and 15 mg was cultured in 100 μ l lipolysis buffer (KRBS buffer plus 0.1% glucose and 3.5% fatty acid free BSA; Sigma) in a 96-well plate for 2 h at 37 °C at 450 r.p.m. For adipose co-culture with young ATMs, adipose tissue was collected from aged fasted mice and aliquoted into a 96-well plate. Sorted young F4/80 + CD11b + cells were spiked in and glycerol or FFA levels were measured after overnight culture. For adipocyte co-culture with old ATMs, sorted old F4/80 + CD11b + cells (from n = 8 aged mice), were spiked into adipocytes at 10,000 cells per well. 10 μ M noradrenaline was added after 1 h to induce lipolysis, glycerol or FFA were measured after 1 h stimulation. The glycerol assay (Sigma) or NEFA assay (Wako Diagnostics) was used to measure lipolysis, as per manufacturer's instructions. Adipocyte generation. Adipocyte precursors were collected from subcutaneous adipose tissue as previously described 30, 31 . In brief, FACS-isolated precursors were cultured in DMEM (ATCC), 10% FBS (Gibco), and 1% penicillin/streptomycin (Sigma-Aldrich). Once at confluence, cells were maintained without changing the media for 2 days. Cells were then differentiated for 7-9 days in adipogenic differentiation media (growth media supplemented with 0.1 μ g ml −1 insulin (Sigma-Aldrich)) that was changed every 2 days. Generation of BMDMs and co-culture design. All steps were performed using sterile techniques. Femurs were collected in RPMI (Life Technologies). Using a needle and syringe, marrow was flushed into RPMI containing 10% FBS (Omega Scientific) and 5% antibacterial/antimycotics (Life Technologies). Red blood cells were lysed using ACK lyses buffer (Quality Biological) and lysis was neutralized with complete RPMI. Bone marrow cells were differentiated into macrophages using MCSF (10 ng ml −1 ; R&D) and L929 (ATCC; authenticated and tested by ATCC upon purchase) conditioned media. Non-adherent cells were collected on day 7, counted and replated. BMDMs were treated on day 8. Cells were primed by 4-h treatment with ultrapure LPS (1 μ g ml −1 ; Sigma) alone; inflammasome stimulation was provided by treatment with ATP (5 mM; 1 h). For co-culture with adipose, BMDMs were treated as described, media removed, cells washed and weighed VAT added to culture. VAT was stimulated with 1 μ M noradrenaline after 1 h, and glycerol or FFA was measured at assay end. MAOA inhibition. For cell culture experiments, BMDMs were treated with clorgyline (10 μ M) 12 h before LPS stimulation. For in vivo treatment, mice received an intraperitoneal injection of clorgyline (2 mg kg −1 ) or vehicle control at 12 h before the start of fasting and at the start of fasting. Fasting lasted for 24 h. Western blot. Immunoblots were performed as described previously 18, 19 . Samples were left on ice for 1 h with vortexing every 10 min to disrupt membranes. Samples were centrifuged at 14,000g for 15 min, supernatant was collected and protein concentration was quantified using the DC protein assay (Bio-Rad). Noradrenaline quantification. Noradrenaline concentration in VAT was measured using reverse-phase high performance liquid chromatography (HPLC) 32 . In brief, each frozen VAT sample was sonicated in acid and then centrifuged, with the supernatant adsorbed on an alumina column at pH 8.6. After washing the column, catechols were eluted in acid, then separated by HPLC using electrochemical detection; quantification was achieved by reference to internal and external standards. Whole-mount staining. Staining was performed similar to those previously published 33 . In brief, adipose tissue was collected, fixed in 1% PFA and blocked with 5% BSA. Permeabilization was done using 0.1% Triton-X 100 in 5% BSA. The adipose tissue was then stained in primary antibodies over 1-2 days and secondary antibody for 2.5 h in goat blocking serum. Samples were visualized by confocal microscopy using Leica SP8 and analysed using Leica Application Suite AF. Antibodies. For flow cytometry analysis, the following antibodies were used: Letter reSeArCH previously described 34 . Primer sequences used for qPCR: Maoa (F: 5′-GTATGG AAGGGTGATTCGGCA-3′ ; R: 5′-ACTGCACCTTCCATGTAGCC-3′ ), 18S (F: 5′-AACCCGTTGAACCCCATT-3′ ; R: 5′-CCATCCAATCGGTAGTAGCG-3′ ), Casp1 (F: 5′-GGACCCTCAAGTTTTGCCCT-3′ ; R: 5′-AGACGTGTACGA GTGGTTGT-3′ ), Il1b (F: 5′ -GGTCAAAGGTTTGGAAGCAG-3′ ; R: 5′-TGTG AAATGCCACCTTTTGA-3′ ), Hsl (F: 5′-AGGGAGGGCCTCAGCG-3′ ; R: 5′-TTG GCTGGTGTCTCTGTGTC-3′ ), Atgl (F: 5′-GAGGAATGGCCTACTGAACCA-3′ ; R: 5′-GGCTGCAATTGATCCTCCTCT-3′ ), RNA-seq: quality control. Total RNA quality is determined by estimating the A 260 nm /A 280 nm and A 260 nm /A 230 nm ratios by nanodrop. RNA integrity is determined by running an Agilent Bioanalyzer gel, which measures the ratio of the ribosomal peaks. Library prep. mRNA is purified from approximately 500 ng of total RNA with oligo-dT beads and sheared by incubation at 94 °C. Following first-strand synthesis with random primers, second-strand synthesis is performed with dUTP for generating strand-specific sequencing libraries. The cDNA library is then end-repaired, and A-tailed, adapters are ligated and second-strand digestion is performed by uricil-DNA-glycosylase. Indexed libraries that meet appropriate cutoffs for both are quantified by qRT-PCR using a commercially available kit (KAPA Biosystems). Insert size distribution was determined with the LabChip GX or Agilent Bioanalyzer. Samples with a yield of ≥ 0.5 ng μ l −1 are used for sequencing. Flow cell preparation and sequencing. Sample concentrations are normalized to 10 nM and loaded onto Illumina High-output flow cells at a concentration that yields 150-250 million passing filter clusters per lane. Samples are sequenced using 75 bp single-end sequencing on an Illumina HiSeq 2000 according to Illumina protocols. Each sample has a 6-bp index that is incorporated during the library prep. The index sequence is read using a different sequencing primer than the 75-bp sequencing read. The index read happens immediately after the 75-bp read. Data generated during sequencing runs are simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina is spiked into every lane at a concentration of 0.3% to monitor sequencing quality in real time. Data analysis and storage. Signal intensities are converted to individual base calls during a run using the system's real time analysis (RTA) software. Sample de-multiplexing was performed using Illumina's CASAVA 1.8.2 software suite. The data are returned to the user if the sample error rate is less than 2% and the distribution of reads per sample in a lane is within reasonable tolerance. Bioinformatics: alignment and mRNA quantification. Raw fastq-files were aligned against the murine genome version mm10 using TopHat version v2.0.13 35 with all default options. BAM files containing the alignment results were sorted according to the mapping position and then imported into Partek Genomics Suite software, version 6.6 Copyright©; 2016 (PGS). mRNA quantification was performed against the mm10-RefSeq Transcripts database version 2015-05-07 to obtain read counts for each individual RefSeq gene, ending up in a total of 18,719 genes. Data set composition and normalization. Three datasets containing different combinations of samples were assembled. Dataset I was composed of macrophages from 3-and 24-month-old wild-type mice, isolated from VAT or from spleen. Dataset II contained macrophages from 3-and 24-month-old wild-type mice as well as from 24-month-old Nlrp3 −/− mice, isolated from VAT. Dataset III included the same combination of macrophages as dataset II, but isolated from spleen. The read count table of each dataset was normalized separately using DESeq2 36 and then imported back into PGS. Data preprocessing. Each dataset was filtered down to keep expressed genes only. The filtering was achieved by excluding genes, which did not have a mean normalized read count of 20 in at least one of the investigated groups for the corresponding data set. This resulted in 13,954 (I), 13,129 (II) and 13,169 (III) present genes. Furthermore, all normalized count values smaller than 1 were set to 1 to avoid spurious fold changes later on. Multiple test corrections. Whenever stated in relation to differential expression analyses, FDR-adjusted P values were obtained using the Benjamini and Hochberg procedure to account for multiple testing 37 . Global characterization of datasets. The overall structure of each dataset was investigated and visualized using principal component analysis (PCA) and a heat map of the top 1,000 genes with the highest variance within the dataset. In addition, a heat map of the union of differentially expressed genes (between 24-and 3-month-old macrophages in VAT and spleen, respectively, according to a fold change of less than − 1.5 or greater than 1.5, and an FDR-adjusted P < 0.05) was generated for dataset I to further demonstrate the age and tissue induced differences. Functional characterization of changes induced by age in VAT macrophages. To evaluate the overall differences between 24-and 3-month-old VAT macrophages, differentially expressed genes were determined requiring a fold change larger than 1.5 or lower than − 1.5 and an FDR-adjusted P < 0.05. The resulting 779 genes were displayed in the form of a heat map. To characterize those differences on the functional level further, Gene Ontology 38,39 enrichment analysis (GOEA) was performed within PGS based on genes with high variance (2,806) between both conditions according to a P < 0.05. In the Gene Ontology branch of biological processes, the GO term 'metabolic process' was the highest enriched child term according to the normalized enrichment score (NES). Going down this branch, the child term 'organic substance metabolic process' appeared to be the highest enriched one. For each child term of this branch, genes were collected, which were part of the corresponding GO term and which were variable across the 3-and 24-month-old macrophages (among the 2,806 variable genes). Those genes were split into two groups, dependent on whether their expression was higher in 24-month-old (red) or 3-month-old (blue) macrophages. The child terms were then sorted according to the percentages of genes being higher expressed in 24-month-old macrophages, and the top ten were visualized in the form of a bar plot. Furthermore, a scatterplot for the union of all those genes was created to display the differences between the log 2 -expression in 3-and 24-month-old macrophages. In this plot, genes were highlighted being linked to lipid metabolism or belonging to the aldo-keto reductases or aldehyde dehydrogenase gene families.
Relating VAT and spleen macrophages to other tissue-resident macrophages.
To put the 3-and 24-month-old VAT and spleen macrophages into context to other tissue-resident macrophages, the raw data published by Lavin et al. 16 were downloaded from the GEO database (accession number GSE63340), considering macrophages from spleen, lung, small intestine, large intestine and peritoneum, as well as microglia and Kupffer cells 16 . The fastq-files were aligned against the murine genome version mm10 using TopHat version v2.0.13 with default options. The aligned BAM files were then imported into PGS together with the BAM files of dataset I. The mRNA quantification was performed against the mm10-RefSeq Transcripts database version 2015-05-07, resulting in 19,764 detected genes. The two datasets were normalized together using DESeq2 and imported back into PGS. Since both datasets contained macrophages isolated from the spleen, the 3-month spleen macrophages and the spleen macrophages from GSE63340 were defined as bridging samples. The two datasets were considered as two different batches and the bridging samples allowed to remove the impact, which was introduced by the two different runs. The batch-corrected dataset was then reduced to present genes only (again, at least one of the group means of normalized read counts had to be larger than 20) , and the minimal normalized count value was set to 1. The remaining 13,855 genes were displayed within a PCA, showing principal component 1 (PC1) versus PC2. Comparison of VAT and spleen macrophages to human in vitro activated monocyte-derived cells. To link the signatures of VAT and spleen tissue macrophages to signatures derived from in vitro activated macrophages, the list of present genes of dataset I were used as input for CIBERSORT 40 . As signature matrix, 29 macrophage subsets including inactivated human macrophages were used 41 . On the basis of linear support vector regression using all default options, the relative fractions of the 29 macrophage subsets were determined for the VAT and spleen macrophages. Human and mouse symbols were translated based on one-to-one orthologues. Co-expression network of VAT and spleen macrophages. Using an FDR-adjusted P < 0.05, 6,968 variable genes (genes of high variance) were determined across the four groups (3-month and 24-month-old macrophages isolated from both VAT and spleen) of dataset I. Those genes were imported into BioLayout Express 3D version 3.3 42 . Requiring a correlation of at least 0.98 between the expression profiles of two genes, a co-expression network was generated. After excluding smaller network subclusters containing less than 20 genes, two separate networks composed of 1,887 genes in total remained. For each of the four conditions, the fold change of the respective condition compared to the overall mean was mapped onto the networks using Cytoscape version 3.2.0 43 . The fold changes were displayed in colours ranging from blue (negative fold change) over white to red (positive fold change). Finally, the networks were divided into four main clusters based on the patterns revealed by the fold change mappings. Clusters 1 to 4 were composed of 334, 818, 406 and 329 genes, respectively. Functional characterization based on clusters defined by the co-expression network. On the basis of the genes of the four clusters defined by the co-expression network, GOEA was performed within PGS separately for each cluster. Genes associated with lipid metabolism were identified based on literature search using PubMed. Genes were included in our 'lipid metabolism' list, if publications were found that provided association between 'gene X' and 'lipid' , 'fat' or 'adipose' and 'macrophage' . Age-dependent gene expression differences for members of the NOD-like receptor signalling pathway. On the basis of genes being significantly upregulated (fold change > 1.5 and FDR-adjusted P < 0.05) between 24-month and 3-monthold VAT macrophages, pathway enrichment analysis was performed within PGS. Among other KEGG pathways, the 'NOD-like receptor signalling pathway' Letter reSeArCH (mmu04621) was significantly enriched in 24-month old VAT macrophages (P = 0.0361706). To highlight the expression pattern of all individual members being present in the dataset, the fold changes between 24 and 3 months were mapped onto the gene symbols, ranging from blue (negative fold change) over white (no change) to red (positive foldchange) using PGS. Identification of genes being rescued by Nlrp3 −/− . To identify genes having expression patterns, which are similar in 3-month wild-type and 24-month Nlrp3 −/− macrophages, but are different in 24-month wild-type ones, two different types of genes list were created. On the one hand, genes were identified being upregulated in the 24-month compared to the 3-month wild-type macrophages with a fold change > 2. On the other hand, genes were collected being down regulated in 24-month Nlrp3 −/− compared to 24-month wild-type macrophages with a fold change < − 2. Taking the intersection of these two lists revealed genes that had a high expression in 24-month wild-type macrophages, but whose expression was decreased in 24-month Nlrp3 −/− macrophages to a comparable level as in the 3-month wild-type macrophages. The same analysis was also performed into the other direction (fold change for 24-month versus 3-month wild-type macrophages < − 2, and fold change for 24-month Nlrp3 −/− versus 24-month wild-type macrophages > 2) to obtain genes being rescued in the sense of downregulation. The whole approach was performed separately for datasets II and III to identify genes being rescued in VAT and spleen macrophages independently. The resulting numbers behind the approach were visualized in the form of Venn diagrams. Finally, the top 20 genes, determined and sorted according to the highest expression in 24-month wild-type macrophages, were plotted in heat maps for all four resulting lists of rescued genes.
Behaviour of genes linked to senescence on transcriptional level in VAT macrophages.
On the basis of previous publications 44, 45 , a list of genes being linked to senescence was curated. Of those, only those were kept that had a fold change > 1.5 or < − 1.5 between 24-month and 3-month-old wild-type VAT macrophages, together with a corresponding P < 0.05 in dataset II. For the remaining genes, a bar plot displaying the fold change between 24-month and 3-month-old wild-type VAT macrophages (in pink) and between 24-month-old Nlrp3 −/− and 24-month-old wild-type VAT macrophages (in turquoise) was created.
Highlighting functional differences between VAT and spleen macrophages.
Using the curated list of genes associated with lipid metabolism as well as an assembly of genes being linked to lipid metabolism or belonging to the aldo-keto reductases or aldehyde dehydrogenases gene families, heat maps were generated for those genes being expressed in VAT (dataset II) macrophages. The genes were ordered based on hierarchical clustering. The same genes were then displayed within a heat map based on the spleen macrophage data (dataset III), using the same order as for the VAT macrophages. Genes being not expressed in the spleen dataset were left blank within the heat maps. Data availability. Sequencing data are available at the Gene Expression Omnibus (GEO) GSE93202. Full scans for all western blots (Fig. 4b, h 
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Extended Data Figure 1 | Age-related adipose tissue defects in response to fasting. Data are related to Fig. 1 . a, Body weight after 24 h feeding or fasting. n = 13 4-month fed; n = 10 21-month fed; n = 16 21-month fasted; n = 11 21-month fasted pooled from 2 independent experiments. b, Percentage body weight change after 24 h fasting. n = 13 4-month fed; n = 10 21-month fed; n = 16 21-month fasted; n = 11 21-month fasted pooled from 2 independent experiments. c, Blood glucose. n = 6 4-month fed; n = 6 21-month fed; n = 8 21-month fasted; n = 7 21-month fasted. d, Percentage change in blood glucose after feeding or fasting. n = 6 4-month fed; n = 6 21-month fed; n = 8 21-month fasted; n = 7 21-month fasted. e, VAT weight, displayed as a percentage of fed. n = 13 4-month fed; n = 10 21-month fed; n = 16 21-month fast; n = 11 21-month fasted pooled from 2 independent experiments. f, Serum FFA levels in fed and fasted mice. Data are pooled from 4 independent experiments. n = 23 4-month fed; n = 13 21-month fed; n = 26 4-month fasted; n = 13 21-month fasted. Each symbol represents an individual mouse. g, Bodyweight, VAT weight, serum FFA levels, glycerol and FFA release from VAT explants in 4-month-old fed, 12-h fasted or 24-h fasted animals. Data are pooled from 2 independent experiments. n = 10 fed; n = 10 12-h fasted; n = 5 24-h fasted. h, Hsl and Atgl gene expression in floating adipocytes isolated from VAT of 4-(black) or 21-(red) month-old mice that were fed or fasted for 24 h. n = 5 4-month fed; n = 6 21-month fed; n = 6 4-month fasted; n = 9 21-month fasted pooled from 2 independent experiments. i, Western blot of lipolytic signalling pathway (pHSL, HSL, ATGL) in VAT from 4-or 21-month-old mice fed or fasted for 12 h. Each lane is an individual animal that received indicated treatment. Actin was probed for as a loading control. Representative of one experiment. j, Western blot of lipolytic signalling pathway (pHSL, HSL, ATGL) in VAT explants from 4-or 21-month-old fed mice that were left unstimulated or stimulated with 1 μ M noradrenaline. Each lane represents a biological replicate. Representative of two individual experiments. Actin was probed for as a loading control. In all graphs (a-h), each symbol represents an individual mouse and data are mean ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001, Tukey's test (a-h).
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Experimental design 1. Sample size
Describe how sample size was determined. An 'N' for each experiment was used based on preliminary and published experiments, which identified Ns needed for statistical analysis.
Data exclusions
Describe any data exclusions. GraphPad Prism was used to define statistical outliers, which were then excluded from data analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
All experiments contain biological replicates. Experiments that were repeated on different days showed reproducibility independent of minor day-to-day variation
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Control and experimental groups were randomly assigned by cage. All experiments contained littermates and non-littermates, which were both randomly assigned to control and experimental group.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding of investigators was not possible during experiments.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
